Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-12-31 Exercise | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 7,337 | $0 | 5,176 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 2,161 | $17.67 | 5,176 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:09 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:22 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:54 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 7,337 | $0 | 7,337 (Direct) | View |
| 2019-12-06 Option Award | 2019-12-09 5:58 pm | N/A 2029-12-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2019-11-25 5:48 pm | N/A 2028-09-03 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 0 | $0 | 148,000 (Direct) | View |